DOA
MRNA icon

D'Orazio & Associates’s Moderna MRNA Stock Holding History

D'Orazio & Associates’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-347
Closed -$134K – 471
2021
Q3 		$134K Buy
347
+47
+16% +$17.3K 0.03% 115
2021
Q2 		$70K Hold
300
– – 0.02% 147
2021
Q1 		$39K Hold
300
– – 0.01% 185
2020
Q4 		$31K Hold
300
– – 0.01% 187
2020
Q3 		$21K Sell
300
-500
-63% -$34.9K 0.01% 194
2020
Q2 		$51K Buy
+800
New +$43.8K 0.02% 138

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D'Orazio & Associates's MRNA Position: Q4 2021 in Review

D'Orazio & Associates sold out of Moderna (MRNA) in Q4 2021, closing a stake of 347 shares — an estimated $134K sold.

D'Orazio & Associates first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $134K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • D'Orazio & Associates reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • D'Orazio & Associates sold 347 Moderna shares in Q4 2021, an estimated $134K.
  • D'Orazio & Associates first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • D'Orazio & Associates's Moderna position peaked at $134K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.